| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 73,383 | 84,578 | 65,146 | 113,121 | | Cost of Revenue | 55,746 | 63,509 | 51,870 | 84,472 | | | Gross Profit | 17,637 | 21,069 | 13,276 | 28,649 | | | Operating Expenses | | Research Development | 1,331 | 1,346 | 1,619 | 1,741 | | Selling General and Administrative | 12,773 | 12,186 | 12,106 | 15,112 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,533 | 7,537 | (449) | 11,796 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 243 | 836 | 463 | (1,390) | | Earnings Before Interest And Taxes | 3,776 | 8,373 | 14 | 10,406 | | Interest Expense | 460 | 465 | 480 | 625 | | Income Before Tax | 3,316 | 7,908 | (466) | 9,781 | | Income Tax Expense | 1,234 | 2,639 | (616) | 3,459 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,082 | 5,269 | 150 | 6,322 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,082 | 5,269 | 150 | 6,322 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,082 | $5,269 | $150 | $6,322 |
|
0.13% Nasdaq 
0.11%
Income Statement
